Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
European Journal of Endocrinology
|
August 7, 2017
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma
Giuseppe Reimondo, Soraya Puglisi, Barbara Zaggia, et al.
European Journal of Endocrinology
|
August 3, 2005
Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma
Massimo Terzolo, Silvia Bovio, Anna Pia, et al.
Clinical Endocrinology
|
April 16, 2008
GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment
Annamaria Colao, Massimo Terzolo, Marta Bondanelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 18, 2025
Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells
Aurora Schiavon, Laura Saba, Carlotta Evaristo, et al.
Endocrine Connections
|
October 24, 2018
Preoperative treatment with metyrapone in patients with Cushing's syndrome due to adrenal adenoma: a pilot prospective study
Soraya Puglisi, Paola Perotti, Mattia Barbot, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
June 9, 2011
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion in a 3-year-old child
Patrizia Matarazzo, Gerdi Tuli, Daniele Tessaris, et al.
European Journal of Endocrinology
|
January 19, 2023
The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients
Anna Calabrese, Soraya Puglisi, Chiara Borin, et al.
European Journal of Endocrinology
|
August 21, 2008
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
Giuseppe Reimondo, Silvia Bovio, Barbara Allasino, et al.
Endocrine-Related Cancer
|
September 21, 2005
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
Alfredo Berruti, Massimo Terzolo, Paola Sperone, et al.
Endocrine-Related Cancer
|
October 1, 2008
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
Fulvia Daffara, Silvia De Francia, Giuseppe Reimondo, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
European Journal of Endocrinology
|
August 7, 2017
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma
Giuseppe Reimondo, Soraya Puglisi, Barbara Zaggia, et al.
European Journal of Endocrinology
|
August 3, 2005
Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma
Massimo Terzolo, Silvia Bovio, Anna Pia, et al.
Clinical Endocrinology
|
April 16, 2008
GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment
Annamaria Colao, Massimo Terzolo, Marta Bondanelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 18, 2025
Mitotane activates ATF4/ATF3 axis triggering endoplasmic reticulum stress in adrenocortical carcinoma cells
Aurora Schiavon, Laura Saba, Carlotta Evaristo, et al.
Endocrine Connections
|
October 24, 2018
Preoperative treatment with metyrapone in patients with Cushing's syndrome due to adrenal adenoma: a pilot prospective study
Soraya Puglisi, Paola Perotti, Mattia Barbot, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
June 9, 2011
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion in a 3-year-old child
Patrizia Matarazzo, Gerdi Tuli, Daniele Tessaris, et al.
European Journal of Endocrinology
|
January 19, 2023
The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients
Anna Calabrese, Soraya Puglisi, Chiara Borin, et al.
European Journal of Endocrinology
|
August 21, 2008
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome
Giuseppe Reimondo, Silvia Bovio, Barbara Allasino, et al.
Endocrine-Related Cancer
|
September 21, 2005
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
Alfredo Berruti, Massimo Terzolo, Paola Sperone, et al.
Endocrine-Related Cancer
|
October 1, 2008
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly
Fulvia Daffara, Silvia De Francia, Giuseppe Reimondo, et al.
Page
of 8